Carlisle Companies
CSL
$355.26
+2.48%
Carlisle Companies Inc. is a diversified industrial holding company primarily focused on manufacturing and selling single-ply roofing products, warranted roof systems, and building envelope solutions for the commercial construction industry. It operates as a market leader in its niche through two core segments: Carlisle Construction Materials, which is the dominant revenue driver producing premium roofing membranes and insulation, and Carlisle Weatherproofing Technologies, which provides waterproofing and air barrier systems. The current investor narrative centers on the company's ability to navigate cyclical pressures in the construction sector, as recent quarterly results show a significant sequential decline in revenue and profitability, raising questions about near-term demand and the effectiveness of its strategic focus on high-performance building products.…
CSL
Carlisle Companies
$355.26
Investment Opinion: Should I buy CSL Today?
Rating: Hold. The core thesis is that CSL presents a classic 'value trap' scenario—attractive valuation and cash flow are offset by clear and accelerating fundamental deterioration, making it prudent to wait for evidence of stabilization before committing capital. Analyst sentiment is mixed but leans cautiously optimistic, with firms like JP Morgan maintaining 'Overweight' ratings.
Supporting evidence for the Hold rating includes: 1) A forward P/E of 15.67x, a discount to the stock's own historical norms, 2) Robust trailing FCF of $970.6M supporting financial flexibility, 3) A high current ratio of 3.09 ensuring liquidity, and 4) Analyst forward EPS estimates clustering tightly around $27.14, implying the market is pricing in a P/E of only 13.3x, suggesting embedded skepticism. However, these positives are counterbalanced by the severe Q4 revenue growth of 0.43% and margin compression.
The thesis would upgrade to a Buy if the forward P/E compresses below 14x (implying further price decline without estimate cuts) concurrent with a stabilization or sequential improvement in quarterly revenue and gross margin. It would downgrade to a Sell if revenue growth turns negative YoY or if gross margins fall below 30%, confirming a deeper cyclical downturn. Based on the current data, the stock appears fairly valued relative to its near-term risk/reward profile—neither egregiously overvalued nor compellingly cheap enough to ignore the deteriorating fundamentals.
Sign up to view all
CSL 12-Month Price Forecast
The outlook for CSL is one of high uncertainty balanced by valuation support. The fundamental picture has deteriorated meaningfully, as shown by the near-zero revenue growth and margin compression in the latest quarter, justifying the stock's weak price action. However, the company's strong cash generation and balance sheet liquidity provide a floor. The base case is for sideways consolidation as the market waits for clearer signs of the cycle's direction. The stance would upgrade to bullish on evidence of sequential fundamental stabilization (e.g., two quarters of flat or improving margins). It would turn bearish if revenue growth turns negative, confirming the worst fears of a deep cyclical slump.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Carlisle Companies's 12-month outlook, with a consensus price target around $461.84 and implied upside of +30.0% versus the current price.
Average Target
$461.84
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$284 - $462
Analyst target range
Analyst coverage for Carlisle is limited, with only 2 analysts providing estimates, indicating it is a mid-cap stock with less institutional scrutiny which can lead to higher volatility. The consensus sentiment, based on recent institutional ratings, is cautiously optimistic, with firms like JP Morgan and Oppenheimer maintaining 'Overweight' and 'Outperform' ratings, respectively, though Truist and Loop Capital have 'Hold' stances. The average target price is not explicitly provided in the data, but the implied upside must be calculated from estimates; the average EPS estimate for the next period is $27.14, which, against a current price of $360.07, suggests the market is pricing in a forward P/E of 13.3x, below the stated forward P/E of 15.67x, implying potential upside if estimates are met. The target range, inferred from EPS estimates, shows a low of $26.68 and a high of $27.56, a relatively tight spread of about 3.3%, which indicates high conviction in the near-term earnings forecast among the few covering analysts. The recent rating actions show stability, with no downgrades in the latest data, suggesting analysts are currently in a 'wait-and-see' mode regarding the company's ability to execute through the cycle.
Bulls vs Bears: CSL Investment Factors
The evidence currently tilts bearish, as the fundamental deterioration in revenue growth and margins is severe, recent, and aligns with the stock's pronounced technical downtrend. The bull case rests on valuation support and strong cash flow, but these are defensive attributes rather than growth catalysts. The single most important tension in the investment debate is whether the current valuation discount (P/E of 18.48x vs. historical >25x) adequately compensates for the accelerating cyclical downturn evidenced by the Q4 revenue and margin collapse. If the cycle troughs sooner and shallower than feared, the stock could re-rate significantly; if the downturn deepens or prolongs, the valuation 'discount' could prove justified or even expand further.
Bullish
- Strong Free Cash Flow Generation: The company generated $970.6 million in trailing twelve-month free cash flow, providing significant financial flexibility. This robust cash flow supports shareholder returns through stock repurchases and a dividend, and offers a cushion against cyclical downturns.
- Attractive Valuation Discount to History: CSL trades at a trailing P/E of 18.48x, which is well below its own historical 5-year range that has frequently exceeded 25x. This discount suggests the market has already priced in a significant cyclical slowdown, creating a potential value opportunity.
- Analyst Confidence in Forward Earnings: The two covering analysts show high conviction, with a tight EPS estimate range of $26.68 to $27.56 (a 3.3% spread). The average forward EPS of $27.14 implies a forward P/E of 13.3x based on the current price, indicating potential upside if these earnings are met.
- Solid Balance Sheet Liquidity: A current ratio of 3.09 indicates strong short-term liquidity, well above the typical healthy threshold of 2.0. This provides operational resilience and reduces near-term financial risk despite the elevated debt-to-equity ratio.
Bearish
- Severe Revenue and Margin Deceleration: Q4 2025 revenue grew a mere 0.43% YoY, a sharp slowdown from prior quarters. Sequentially, revenue fell from $1.45B in Q2 to $1.13B in Q4, with gross margin compressing from 37.33% to 33.75%, signaling significant end-market softening.
- Pronounced Technical Downtrend and Weakness: The stock is down 5.59% over the past year and has underperformed the SPY by -36.18%. It has experienced a maximum drawdown of -32.11% and is trading at 82.6% of its 52-week range, indicating a strong and persistent bearish trend.
- Elevated Financial Leverage: A debt-to-equity ratio of 1.60 indicates a leveraged capital structure. In a rising interest rate environment, this increases financial risk and could pressure earnings if refinancing costs rise, especially during a cyclical downturn.
- High Dependence on Cyclical Construction: As a commercial construction supplier, CSL's fortunes are tightly linked to a cyclical industry. The sequential revenue decline from Q2 to Q4 2025 provides concrete evidence that the cycle may be turning negative, posing a fundamental threat to near-term performance.
CSL Technical Analysis
The stock is in a pronounced downtrend from its recent highs, trading at approximately 82.6% of its 52-week range based on a current price of $360.07 relative to its 52-week high of $435.92 and low of $293.43. Despite a positive 1-year price change of -5.59%, the stock has experienced a sharp correction, with a maximum drawdown of -32.11%, indicating significant volatility and a failure to sustain momentum. Recent momentum shows a stark divergence; the stock has gained 5.92% over the past month but is up only 3.13% over the past three months, suggesting the recent uptick may be a technical rebound within a larger corrective phase rather than a trend reversal, especially given its severe underperformance relative to the SPY over the past year (-36.18% relative strength). Key technical levels are clearly defined, with immediate resistance near the 52-week high of $435.92 and strong support at the 52-week low of $293.43. A sustained break below the $293 support would signal a continuation of the bearish trend, while reclaiming the $400 level is necessary to suggest a more durable recovery. The stock's beta of 0.951 indicates market-like volatility, but the extreme drawdown highlights idiosyncratic risk, necessitating careful position sizing.
Beta
0.95
0.95x market volatility
Max Drawdown
-32.1%
Largest decline past year
52-Week Range
$293-$436
Price range past year
Annual Return
-6.4%
Cumulative gain past year
| Period | CSL Return | S&P 500 |
|---|---|---|
| 1m | +6.5% | +10.5% |
| 3m | +4.2% | +3.9% |
| 6m | +9.3% | +5.4% |
| 1y | -6.4% | +29.6% |
| ytd | +8.2% | +5.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CSL Fundamental Analysis
Revenue growth has decelerated sharply, with Q4 2025 revenue of $1.13 billion representing a mere 0.43% year-over-year increase, a significant slowdown from the stronger growth seen in prior quarters of 2025 (e.g., Q2 revenue was $1.45 billion). The multi-quarter trend shows a sequential decline from $1.45 billion in Q2 to $1.13 billion in Q4, indicating potential softening end-market demand. Profitability remains intact but under pressure; the company reported net income of $127.4 million for Q4 2025, with a net margin of 11.3% and a gross margin of 33.75%. However, margins have compressed from the higher levels seen earlier in the year (e.g., Q2 2025 net margin was 17.65% and gross margin was 37.33%), reflecting less favorable operating leverage and potentially rising costs. The balance sheet and cash flow position is a relative strength, with a robust current ratio of 3.09 and strong trailing twelve-month free cash flow of $970.6 million. However, the debt-to-equity ratio of 1.60 indicates a leveraged capital structure. The substantial FCF generation, yielding a high FCF/Share, provides financial flexibility for shareholder returns, as evidenced by significant stock repurchases, but the elevated debt level warrants monitoring in a rising rate environment.
Quarterly Revenue
$1.1B
2025-12
Revenue YoY Growth
+0.00%
YoY Comparison
Gross Margin
+0.33%
Latest Quarter
Free Cash Flow
$970600000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CSL Overvalued?
Given the company's positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 18.48x, while the forward P/E is notably lower at 15.67x, indicating the market expects earnings growth or a recovery from recent depressed levels. Compared to sector averages, Carlisle's valuation presents a mixed picture; its trailing P/E of 18.48x is below the implied industry average from its own historical context (often in the 20s), suggesting a relative discount. Its Price/Sales ratio of 2.73x and EV/EBITDA of 12.63x need to be assessed against industrial peers, but the discount likely reflects concerns over the growth deceleration. Historically, the stock's current trailing P/E of 18.48x sits well below its own 5-year range observed in the data, which has frequently exceeded 25x, indicating it is trading at a discount to its historical valuation norms. This discount suggests the market is pricing in a more pessimistic outlook regarding the cyclical downturn in construction markets, presenting a potential value opportunity if the company can stabilize its earnings trajectory.
PE
18.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 7x~42x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on cyclical pressure and leverage. Revenue growth has decelerated sharply to 0.43% YoY in Q4 2025, with a clear sequential decline from $1.45B to $1.13B over the last three reported quarters. Concurrently, gross margins compressed from 37.33% to 33.75%, indicating deteriorating operating leverage. While free cash flow of $970.6M is strong, the debt-to-equity ratio of 1.60 introduces vulnerability if earnings decline further in a downturn, potentially straining the company's ability to maintain shareholder returns while servicing debt.
Market & Competitive Risks are heightened by CSL's sector sensitivity and valuation. The stock's beta of 0.951 suggests market-like volatility, but its -36.18% relative underperformance vs. the SPY over the past year indicates severe idiosyncratic, sector-specific selling pressure. Trading at a forward P/E of 15.67x, the stock is at a discount to its own history, but remains exposed to further multiple compression if the construction cycle weakens more than expected. As a niche player in commercial roofing, it also faces competitive and pricing pressures if commercial construction activity slows materially.
The Worst-Case Scenario involves a prolonged downturn in commercial construction, triggering consecutive quarters of revenue declines and further margin compression. This could lead to earnings misses, analyst downgrades, and a re-test of the 52-week low of $293.43. Combined with a potential de-rating to a lower historical P/E multiple (e.g., 15x), this scenario could see the stock decline approximately -35% from the current price of $360.07 to the $235-$250 range, exceeding the previous low. The chain of events would be: weaker-than-expected guidance in the next earnings report, followed by institutional selling and a break below the $293 technical support level, accelerating the decline.
FAQ
The key risks are, in order of severity: 1) Cyclical Demand Risk: Revenue growth has already slowed to 0.43% YoY, and a deeper downturn in commercial construction could lead to outright declines. 2) Financial Leverage Risk: A debt-to-equity ratio of 1.60 could amplify pain if earnings fall in a downturn or refinancing costs rise. 3) Margin Compression Risk: Gross margin fell from 37.33% to 33.75% from Q2 to Q4 2025; further compression would directly hit profitability. 4) Technical & Sentiment Risk: The stock has underperformed the SPY by -36.18% over the past year and has high short interest (short ratio 5.32), indicating negative momentum that could feed on itself.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $360 and $390, as the current cyclical slowdown plays out without major surprises. The Bull Case (25% probability) targets a return to the 52-week high of $435.92 and beyond, on a faster-than-expected recovery. The Bear Case (15% probability) warns of a re-test of the 52-week low of $293.43 if the downturn deepens. The most likely outcome is the Base Case, which assumes flattish revenue growth, stable margins, and a range-bound valuation multiple. The key assumption is that the construction cycle does not deteriorate significantly from current levels.
CSL appears fairly valued to slightly undervalued relative to its own history, but this is justified by deteriorating fundamentals. Its trailing P/E of 18.48x is well below its historical 5-year range, which has frequently been above 25x, suggesting a discount. Compared to sector peers, its Price/Sales of 2.73x and EV/EBITDA of 12.63x are not excessive for a market leader. However, this valuation implies the market expects earnings to be cyclical and is not pricing in significant growth. The discount is a reflection of the risk that the current slowdown worsens. Therefore, the stock is fairly valued for the near-term risk/reward profile it presents.
CSL is a conditional buy only for patient, value-oriented investors. At its current forward P/E of 15.67x, it trades at a discount to its own history, and its strong $970.6M free cash flow provides downside support. However, it is not a good buy for all investors, given the clear evidence of a cyclical slowdown with Q4 revenue growth of just 0.43% and margin compression. The biggest risk is a prolonged construction downturn leading to further earnings erosion. It could be a good buy for a portfolio seeking cyclical exposure on the cheap, but investors should be prepared for volatility and may want to wait for a confirmed stabilization in quarterly fundamentals before establishing a full position.
CSL is unsuitable for short-term trading due to its cyclical nature, market-like volatility (beta 0.951), and current lack of positive momentum catalysts. It is better suited for a long-term investment horizon of 3-5 years, allowing time for the construction cycle to trough and recover. The company's strong free cash flow and history of shareholder returns (buybacks, 1.32% dividend yield) support a long-term holding strategy. Investors should be prepared to hold through potential near-term weakness. A minimum holding period of 18-24 months is suggested to potentially realize the benefits of cyclical recovery and valuation mean reversion.